Loading...
Loading...
Among the 6 tracked institutional investors we monitor, MTNB (MATINAS BIOPHARMA HLDGS INC) is held with a combined value of $107.62K across 204,972 shares. The largest holder is VANGUARD GROUP INC with a position worth $35.00K (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 2 funds reduced their position.
Total Institutional Value
$107.62K
Total Shares Held
204,972
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $35.00K | 0.00% | New |
| 2 | CITADEL ADVISORS LLC | $25.85K | 0.00% | -21.4% |
| 3 | BlackRock, Inc. | $24.82K | 0.00% | - |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $14.29K | 0.00% | -1.4% |
| 5 | STATE STREET CORP | $7.66K | 0.00% | - |
| 6 | FMR LLC | $4 | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of MTNB with a position worth $35.00K, representing 0.00% of their portfolio. In total, 6 institutional investors hold MTNB with a combined value of $107.62K.
In the most recent quarter, 2 funds opened a new position in MTNB. Additionally, 2 reduced their positions.
Institutional investors hold $107.62K worth of MTNB stock across 6 positions. The largest institutional holder is VANGUARD GROUP INC with $35.00K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For MTNB, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their MTNB positions.